BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16574462)

  • 1. [Minimal ovarian stimulation: certainly less dangerous and probably as efficient].
    Emperaire JC
    Gynecol Obstet Fertil; 2006 Apr; 34(4):354-5. PubMed ID: 16574462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Minimal ovarian stimulation: certainly less dangerous but rarely as efficient].
    Antoine JM; Verstraete L
    Gynecol Obstet Fertil; 2006 Apr; 34(4):356-7. PubMed ID: 16564729
    [No Abstract]   [Full Text] [Related]  

  • 3. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
    Zarek SM; Muasher SJ
    Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulsatile gonadotropin releasing hormone treatment following previous ovarian hyperstimulation].
    Koloszár S; Bártfai G
    Orv Hetil; 1993 Jul; 134(28):1521-3. PubMed ID: 8341530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing attitudes in ovarian stimulation.
    Al-Inany H; Wahba A; Peitsidis P
    Womens Health (Lond); 2011 Sep; 7(5):505-7. PubMed ID: 21879817
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of GnRH antagonists in ovarian stimulation for intrauterine inseminations: is there any interest?].
    Pasquier M; Maitrot L; Leperlier F; Dehghani C; Snaifer E; Durnerin IC; Hugues JN
    Gynecol Obstet Fertil; 2008 Jun; 36(6):644-9. PubMed ID: 18539072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing ovarian hyperstimulation with gonadotropin-releasing hormone agonist trigger: is anything perfect?
    Filicori M
    Fertil Steril; 2014 Apr; 101(4):936-7. PubMed ID: 24613536
    [No Abstract]   [Full Text] [Related]  

  • 10. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
    Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
    Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
    Kumbak B; Kahraman S
    Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An aborted revolution].
    Cohen J
    Gynecol Obstet Fertil; 2006 Apr; 34(4):353. PubMed ID: 16564731
    [No Abstract]   [Full Text] [Related]  

  • 16. Ovarian explosion following ovarian stimulation.
    Taheripanah R; Taslimi S; Karimzadeh MA; Aflatoonian A; Zekavat H
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):808. PubMed ID: 21488842
    [No Abstract]   [Full Text] [Related]  

  • 17. 'GnRH agonist trigger: looking for the coin under the lamp post?'.
    Kol S
    Hum Reprod; 2006 May; 21(5):1328; author reply 1328-9. PubMed ID: 16611976
    [No Abstract]   [Full Text] [Related]  

  • 18. Follicular recruitment is reduced in minimal stimulation for controlled ovarian hyperstimulation using purified human menopausal gonadotropin compared with follicle-stimulating hormone.
    Park JK; Clark R; Session DR
    Fertil Steril; 2009 Apr; 91(4 Suppl):1434-6. PubMed ID: 18701097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New advances in ovulation induction.
    Kafy S; Tulandi T
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):248-52. PubMed ID: 17495641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
    Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.